Zoloft

Zoloft. It is a prescription medication belonging to the class of drugs known as selective serotonin reuptake inhibitors, widely used in the treatment of major depressive disorder and several other psychiatric conditions. First approved for medical use in the United States by the Food and Drug Administration in 1991, it has since become one of the most commonly prescribed antidepressants globally. The active pharmaceutical ingredient, sertraline, functions by increasing the levels of the neurotransmitter serotonin within the synaptic cleft of the brain.

Medical uses

Approved indications include major depressive disorder, obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder, premenstrual dysphoric disorder, and social anxiety disorder. Clinical guidelines from organizations like the American Psychiatric Association often recommend it as a first-line treatment for these conditions. It is also used off-label for conditions such as generalized anxiety disorder and certain eating disorders. The efficacy for its approved uses has been demonstrated in numerous randomized controlled trials conducted by institutions like the National Institute of Mental Health.

Adverse effects

Common side effects include nausea, diarrhea, insomnia, dry mouth, fatigue, and sexual dysfunction such as decreased libido or anorgasmia. A potential serious adverse effect is serotonin syndrome, a potentially life-threatening condition that can occur when combined with other serotonergic drugs like tramadol or St. John's wort. There is an FDA-mandated black box warning regarding an increased risk of suicidal thinking and behavior in children, adolescents, and young adults, a finding that emerged from analyses by regulators like the Medicines and Healthcare products Regulatory Agency.

Pharmacology

Sertraline acts primarily as a potent and selective inhibitor of the serotonin transporter protein, thereby blocking the reuptake of serotonin into the presynaptic neuron. It has very weak affinity for adrenergic, cholinergic, GABAergic, dopaminergic, and histaminergic receptors. The drug is extensively metabolized in the liver by cytochrome P450 enzymes, primarily CYP2B6, CYP2C9, CYP2C19, CYP2D6, and CYP3A4, into the less active metabolite desmethylsertraline. Its pharmacokinetic profile was extensively studied by its original developer, Pfizer.

History

Sertraline was discovered and developed in the 1970s by the pharmaceutical company Pfizer following research into compounds with tricyclic antidepressant-like structures but improved selectivity. The drug received its initial approval from the FDA in 1991, following successful clinical trials. It subsequently gained approval in numerous other countries, including authorization from the European Medicines Agency. The expiration of its primary patent in the early 2000s led to the widespread availability of generic versions manufactured by companies like Teva Pharmaceutical Industries.

Society and culture

The drug has been the subject of significant media attention and legal proceedings, including lawsuits related to its side effects and allegations of improper marketing. It has appeared in various works of popular culture, including films and literature, often reflecting broader societal conversations about mental health treatment. The medication is on the World Health Organization's List of Essential Medicines, highlighting its importance in global health systems. Sales of the brand-name version were a major revenue driver for Pfizer during its patent-exclusive period.

Category:Drugs